1. Home
  2. AGIO vs GTY Comparison

AGIO vs GTY Comparison

Compare AGIO & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.39

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

HOLD

Current Price

$28.48

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
GTY
Founded
2007
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AGIO
GTY
Price
$27.39
$28.48
Analyst Decision
Buy
Buy
Analyst Count
9
5
Target Price
$32.13
$31.80
AVG Volume (30 Days)
2.7M
380.8K
Earning Date
10-30-2025
10-22-2025
Dividend Yield
N/A
6.80%
EPS Growth
N/A
10.25
EPS
N/A
1.28
Revenue
$44,791,000.00
$214,194,000.00
Revenue This Year
$28.75
$6.23
Revenue Next Year
$139.45
$8.82
P/E Ratio
N/A
$22.33
Revenue Growth
36.26
8.17
52 Week Low
$22.24
$25.39
52 Week High
$46.00
$32.60

Technical Indicators

Market Signals
Indicator
AGIO
GTY
Relative Strength Index (RSI) 37.05 57.93
Support Level $26.80 $27.63
Resistance Level $28.61 $28.79
Average True Range (ATR) 1.19 0.41
MACD 0.25 -0.01
Stochastic Oscillator 56.00 72.08

Price Performance

Historical Comparison
AGIO
GTY

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

Share on Social Networks: